Research Article - (2015) Volume 3, Issue 3
Economic Evaluations of Medical Cost Differences: Use of Targeted-Specific Oral Anticoagulants vs. Warfarin among Patients with Nonvalvular Atrial Fibrillation and Venous Thromboembolism in the U.S.
- Alpesh Amin1*, Melissa Lingohr-Smith2, Amanda Bruno3, Jeffrey Trocio4 and Jay Lin2
- 1University of California, Irvine, CA, USA
- 2Novosys Health, Green Brook, NJ, USA
- 3Bristol-Myers Squibb, Plainsboro, NJ, USA
- 4Pfizer, Inc., New York, NY, USA
*Corresponding Author:
Alpesh Amin,
MD, Chair, Executive Director, Hospitalist Program, Department of Medicine, School of Medicine University of California, Irvine, UCIMC; 101 The City Drive South Building 58, Room 110, ZC-4076H, Mail Code: 4076, Irvine, CA 92868, USA, Tel: 714 456-3785
Email: